Published in Heart on August 01, 2001
Reference values for the incremental shuttle walk test in healthy subjects: from the walk distance to physiological responses. J Bras Pneumol (2013) 1.04
Incremental shuttle and six-minute walking tests in the assessment of functional capacity in chronic heart failure. Can J Cardiol (2008) 0.95
Exploring adaptations to the modified shuttle walking test. BMJ Open (2013) 0.82
Incremental shuttle walk test: Reference values and predictive equation for healthy Indian adults. Lung India (2016) 0.75
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Measuring the accuracy of diagnostic systems. Science (1988) 27.46
Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax (1992) 6.28
Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation (1991) 4.89
Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation (1997) 4.61
Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J (1994) 2.31
Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol (1991) 1.73
Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med (1998) 1.26
Peak VO(2): a simple yet enduring standard. Circulation (2000) 1.25
A shuttle walk test for assessment of functional capacity in chronic heart failure. Am Heart J (1999) 1.12
Shuttle-walk test to assess chronic heart failure. Lancet (1998) 1.10
Shuttle walking test: a new approach for evaluating patients with pacemakers. Heart (1996) 1.03
Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. J Am Coll Cardiol (1998) 0.96
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med (2000) 3.00
Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest (2000) 2.35
Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. Thorax (1984) 2.07
Spatial and temporal operation of the Scotia Sea ecosystem: a review of large-scale links in a krill centred food web. Philos Trans R Soc Lond B Biol Sci (2007) 1.95
Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis. Thorax (1984) 1.82
High-resolution computed tomography scanning in alpha1-antitrypsin deficiency: relationship to lung function and health status. Eur Respir J (2001) 1.71
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J (2001) 1.67
Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax (2000) 1.65
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis (2001) 1.64
Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract. Antimicrob Agents Chemother (1998) 1.62
Transoesophageal echocardiography in anaesthesia and intensive care. Br J Anaesth (1996) 1.61
Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res (1999) 1.57
Use of mortality within 30 days of a COPD hospitalisation as a measure of COPD care in UK hospitals. Thorax (2013) 1.55
ACE inhibition in aortic stenosis: dangerous medicine or golden opportunity? J Hum Hypertens (2001) 1.55
Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax (2005) 1.55
Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol (2001) 1.52
Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J (2000) 1.50
Neuropsychometric outcome following aortic arch surgery: a prospective randomized trial of retrograde cerebral perfusion. J Thorac Cardiovasc Surg (2003) 1.50
Rebreathing during use of the Air-Viva resuscitation bag: a hazard. Br Med J (Clin Res Ed) (1983) 1.50
Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax (2001) 1.48
Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic beta-blockers on human cardiac vagal control. Clin Sci (Lond) (1999) 1.47
Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation (2000) 1.46
Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med (1999) 1.45
Abnormalities of endothelial function in patients with predialysis renal failure. Heart (2000) 1.43
Heparin, deep venous thrombosis, and trauma patients. Am J Surg (1991) 1.42
Use of i.m. temperature probes during cardiopulmonary bypass in humans. Br J Anaesth (1995) 1.41
Guidelines on guidelines. Lancet (2007) 1.39
Surgical repair of ruptured thoracic and thoracoabdominal aortic aneurysms. Br J Surg (2002) 1.38
Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study. Eur Respir J (2005) 1.38
Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest (1996) 1.36
Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis (1997) 1.36
Immune response to Haemophilus parainfluenzae in patients with chronic obstructive lung disease. Clin Diagn Lab Immunol (2000) 1.33
Selective antegrade cerebral perfusion attenuates brain metabolic deficit in aortic arch surgery: a prospective randomized trial. Circulation (2004) 1.33
Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction. Heart (2008) 1.28
The pathogenesis of postinfectious myocarditis. Clin Immunol Immunopathol (1996) 1.28
Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax (2001) 1.27
Sputum sol-phase proteins and elastase activity in patients with cystic fibrosis. Eur J Respir Dis (1984) 1.22
Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatr Cardiol (2005) 1.21
Effect of inhaled sulphur dioxide and carbon particles on heart rate variability and markers of inflammation and coagulation in human subjects. Heart (2005) 1.20
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax (2003) 1.20
Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol (1999) 1.20
Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation. Thorax (1986) 1.19
Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency. Eur Respir J (2000) 1.19
Heart rate variability--a therapeutic target? J Clin Pharm Ther (2002) 1.17
Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet (1987) 1.15
Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab (2008) 1.15
Management of the heartbeating brain-dead organ donor. Br J Anaesth (2012) 1.14
Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol (1995) 1.13
Role of nitric oxide in the regulation of cardiovascular autonomic control. Clin Sci (Lond) (1999) 1.13
Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state. Thorax (1984) 1.13
Resuscitation training for medical students in the United Kingdom--a comparison with the United States of America. Intensive Care Med (1987) 1.12
Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen. Infect Immun (1995) 1.11
Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis (2003) 1.10
Evaluation of PCR in the molecular diagnosis of endocarditis. J Infect (2004) 1.09
Dynamics of respiratory tract colonization by Branhamella catarrhalis in bronchiectasis. Am J Respir Crit Care Med (1995) 1.09
The heart failure revascularisation trial (HEART): rationale, design and methodology. Eur J Heart Fail (2003) 1.07
The natural history of thoracic aortic aneurysm disease: an overview. J Card Surg (1997) 1.06
The chemotactic activity of sputum from patients with bronchiectasis. Am J Respir Crit Care Med (1998) 1.06
A teenager with pacemaker twiddler syndrome. J Pediatr (1997) 1.05
Nitric oxide and cardiac autonomic control in humans. Hypertension (2000) 1.05
Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA (1996) 1.05
Exercise capacity predicts health status in alpha(1)-antitrypsin deficiency. Am J Respir Crit Care Med (2001) 1.05
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J (2000) 1.04
The measurement of extravascular lung water by thermal-green dye indicator dilution. Ann N Y Acad Sci (1982) 1.03
Sudden infant death syndrome in Cardiff, association with epidemic influenza and with temperature - 1955-1974. Int J Epidemiol (1978) 1.02
Detection of myocardial infarction by immunohistological staining for C9 on formalin fixed, paraffin wax embedded sections. J Clin Pathol (1996) 1.01
A case of Haemophilus parainfluenzae pneumonia. Thorax (2000) 1.00
Quality of life in elderly subjects with a diagnostic label of asthma from general practice registers. Eur Respir J (1999) 0.99
Characterization of murine autoimmune myocarditis induced by self and foreign cardiac myosin. Autoimmunity (1999) 0.99
Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis. Thorax (2001) 0.99
Aortic regurgitation in rheumatoid arthritis necessitating aortic valve replacement. Eur J Cardiothorac Surg (1999) 0.98
Coronary arteries from a single coronary ostium in the right coronary sinus: a previously unreported anatomy. Heart (2000) 0.98
Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient. Lancet (1984) 0.98
Activities and sources of beta-lactamase in sputum from patients with bronchiectasis. J Clin Microbiol (1989) 0.98
Fixed performance oxygen masks: an evaluation. Br Med J (Clin Res Ed) (1984) 0.97
Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart. J Physiol (2001) 0.97
The treatment of coronary artery disease in patients with chronic kidney disease. QJM (2006) 0.95
Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg (1998) 0.95
Nebulized amoxicillin in chronic purulent bronchiectasis. Clin Ther (1985) 0.95
Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis. Arthritis Rheum (2001) 0.94
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. Antimicrob Agents Chemother (1999) 0.93
Changing practice of cardiac surgery in adult patients with congenital heart disease. Heart (2005) 0.93
Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children. J Cardiovasc Electrophysiol (1997) 0.93
Homocysteine and atherothrombosis--mechanisms for injury. Eur Heart J (2000) 0.92
Neutrophil chemotaxis in bronchiectasis: a study of peripheral cells and lung secretions. Clin Sci (Lond) (1988) 0.91
Human sputum cathepsin B degrades proteoglycan, is inhibited by alpha 2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C. Biochem J (1991) 0.91
Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome. Lupus (2002) 0.90
Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction. Am J Cardiol (1998) 0.90
The incremental shuttle walking test in elderly people with chronic airflow limitation. Thorax (2002) 0.90
Thoraco-abdominal aneurysm repair in a Jehovah's Witness: maximising blood conservation. Perfusion (2007) 0.90
The echocardiographic assessment of donor heart function prior to cardiac transplantation. Eur J Echocardiogr (2004) 0.89
Chronotropic effects of nitric oxide in the denervated human heart. J Physiol (2002) 0.88